2016

1. A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae

   Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169

2. Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study

   Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680